Vivo Ventures V, LLC

Filings by Vivo Ventures V, LLC span 4 companies, the busiest being Soleno Therapeutics Inc, Lite Strategy, Inc. and Sagent Pharmaceuticals, Inc. In total, 68 filings cover trades dated from 16 May 2007 to 2 December 2019.

Market trades split into 6 purchases (€3.0M) and 39 sales (€18.6M). No amount is published for 2 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants. So far in 2019, the count stands at no purchases and 18 sales.

Half of the purchases are above €642k and half below. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 3 December 2019 came the latest disclosure, an open-market sale for €50k in Soleno Therapeutics Inc. The most recent open-market purchase was published on 19 December 2017, 3,231 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.